ENTRY       K13756                      KO
NAME        PDE6B
DEFINITION  rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta [EC:3.1.4.35]
PATHWAY     ko00230  Purine metabolism
            ko04744  Phototransduction
DISEASE     H00527  Retinitis pigmentosa (RP)
            H00787  Congenital stationary night blindness (CSNB)
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Metabolism
              Nucleotide metabolism
               00230 Purine metabolism
                K13756  PDE6B; rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta
             Organismal Systems
              Sensory system
               04744 Phototransduction
                K13756  PDE6B; rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta
            Enzymes [BR:ko01000]
             3. Hydrolases
              3.1  Acting on ester bonds
               3.1.4  Phosphoric-diester hydrolases
                3.1.4.35  3',5'-cyclic-GMP phosphodiesterase
                 K13756  PDE6B; rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta
DBLINKS     RN: R01234
            GO: 0047555
GENES       HSA: 5158(PDE6B)
            PTR: 461041(PDE6B)
            PPS: 100988192(PDE6B)
            GGO: 101124811(PDE6B)
            PON: 100457051(PDE6B)
            MCC: 704196(PDE6B)
            MCF: 102145527(PDE6B)
            MMU: 18587(Pde6b)
            RNO: 289878(Pde6b)
            CGE: 100766007(Pde6b)
            HGL: 101705017(Pde6b)
            TUP: 102475873(PDE6B)
            CFA: 399653(PDE6B)
            AML: 100464353
            FCA: 101095012(PDE6B)
            PTG: 102957730(PDE6B)
            BTA: 281974(PDE6B)
            BOM: 102284469
            PHD: 102340020(PDE6B)
            CHX: 102168525(PDE6B)
            SSC: 100625130 100625223(PDE6B)
            CFR: 102507583(PDE6B)
            BACU: 103018123(PDE6B)
            LVE: 103090882(PDE6B)
            ECB: 100050793(PDE6B)
            MYB: 102256894(PDE6B)
            MYD: 102754002(PDE6B)
            PALE: 102879188(PDE6B)
            MDO: 100018608(PDE6B)
            SHR: 100928402(PDE6B)
            OAA: 100083769(PDE6B)
            GGA: 395092(PDE6B)
            MGP: 100542971
            TGU: 100224716(PDE6B)
            FAB: 101811029(PDE6B)
            PHI: 102108906(PDE6B)
            APLA: 101790863
            FPG: 101922995
            FCH: 102055049(PDE6B)
            CLV: 102089467
            ASN: 102369029(PDE6B)
            AMJ: 102563945(PDE6B)
            PSS: 102456997(PDE6B)
            CMY: 102935293
            ACS: 100560718
            PBI: 103060629(PDE6B)
            XTR: 100487945
            DRE: 559332(pde6b)
            TRU: 101070486
            MZE: 101467812
            OLA: 101169549
            XMA: 102229431
            LCM: 102364644
            CMK: 103187952(pde6b)
REFERENCE   PMID:17307970
  AUTHORS   Omori K, Kotera J
  TITLE     Overview of PDEs and their regulation.
  JOURNAL   Circ Res 100:309-27 (2007)
REFERENCE   PMID:16102838
  AUTHORS   Lugnier C
  TITLE     Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents.
  JOURNAL   Pharmacol Ther 109:366-98 (2006)
///
